Taoka Chemical Company, Limited (TYO:4113)
Japan · Delayed Price · Currency is JPY 785.00
-16.00 (-2.00%)
Nov 5, 2026, 9:01 AM JST
Taoka Chemical Company Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 31,662 | 33,192 | 29,930 | 28,544 | 30,166 | 32,374 | |
Revenue Growth | -2.77% | 10.90% | 4.86% | -5.38% | -6.82% | 0.99% |
Cost of Revenue | 26,921 | 27,422 | 24,439 | 23,966 | 26,166 | 26,052 |
Gross Profit | 4,741 | 5,770 | 5,491 | 4,578 | 4,000 | 6,322 |
Selling, General & Admin | 2,898 | 2,880 | 2,792 | 2,645 | 2,712 | 2,706 |
Research & Development | 843 | 843 | 812 | 858 | 837 | 907 |
Operating Expenses | 3,741 | 3,723 | 3,604 | 3,503 | 3,549 | 3,613 |
Operating Income | 1,000 | 2,047 | 1,887 | 1,075 | 451 | 2,709 |
Interest Expense | -4 | -4 | -6 | -9 | -8 | -2 |
Interest & Investment Income | 38 | 34 | 22 | 19 | 27 | 25 |
Currency Exchange Gain (Loss) | -1 | -4 | 25 | 14 | -40 | -3 |
Other Non Operating Income (Expenses) | 3 | 2 | 19 | 27 | 8 | 53 |
EBT Excluding Unusual Items | 1,036 | 2,075 | 1,947 | 1,126 | 438 | 2,782 |
Gain (Loss) on Sale of Investments | - | - | - | - | 26 | - |
Gain (Loss) on Sale of Assets | 20 | 20 | 17 | 14 | 19 | 16 |
Asset Writedown | -70 | -35 | -19 | -13 | -6 | -30 |
Other Unusual Items | - | - | 18 | - | - | - |
Pretax Income | 986 | 2,060 | 1,963 | 1,127 | 477 | 2,768 |
Income Tax Expense | 287 | 527 | 485 | 307 | 167 | 705 |
Net Income | 699 | 1,533 | 1,478 | 820 | 310 | 2,063 |
Net Income to Common | 699 | 1,533 | 1,478 | 820 | 310 | 2,063 |
Net Income Growth | -63.06% | 3.72% | 80.24% | 164.52% | -84.97% | -21.11% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Change | -0.00% | - | 0.01% | - | - | 0.02% |
EPS (Basic) | 48.78 | 106.99 | 103.15 | 57.23 | 21.64 | 143.98 |
EPS (Diluted) | 48.78 | 106.99 | 103.15 | 57.23 | 21.64 | 143.98 |
EPS Growth | -63.06% | 3.72% | 80.23% | 164.52% | -84.97% | -21.13% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 1,141 | 2,971 | 2,496 | -2,841 | -3,371 |
Free Cash Flow Per Share | - | 79.63 | 207.34 | 174.20 | -198.28 | -235.27 |
Dividend Per Share | 21.000 | 36.000 | 31.000 | 18.000 | 27.000 | 36.000 |
Dividend Growth | -47.50% | 16.13% | 72.22% | -33.33% | -25.00% | 12.50% |
Gross Margin | - | 17.38% | 18.35% | 16.04% | 13.26% | 19.53% |
Operating Margin | 3.16% | 6.17% | 6.30% | 3.77% | 1.49% | 8.37% |
Profit Margin | 2.21% | 4.62% | 4.94% | 2.87% | 1.03% | 6.37% |
Free Cash Flow Margin | - | 3.44% | 9.93% | 8.74% | -9.42% | -10.41% |
EBITDA | 2,823 | 3,868 | 3,374 | 2,539 | 1,913 | 4,183 |
EBITDA Margin | - | 11.65% | 11.27% | 8.89% | 6.34% | 12.92% |
D&A For EBITDA | 1,823 | 1,821 | 1,487 | 1,464 | 1,462 | 1,474 |
EBIT | 1,000 | 2,047 | 1,887 | 1,075 | 451 | 2,709 |
EBIT Margin | - | 6.17% | 6.30% | 3.77% | 1.49% | 8.37% |
Effective Tax Rate | - | 25.58% | 24.71% | 27.24% | 35.01% | 25.47% |